Preparation method of antimicrobial peptide slow-release microcapsules
A technology for sustained-release microcapsules and antimicrobial peptides, applied in the field of preparation of microcapsules, can solve the problems of difficulty in forming industrialized large-scale production, lack of sustained-release coating for antimicrobial peptides, and the like, and achieve the effect of uniform embedding
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
specific Embodiment approach 1
[0014] Embodiment 1: In this embodiment, antibacterial peptide sustained-release microcapsules are prepared according to the following steps:
[0015] 1. Mix the sodium alginate aqueous solution and chitosan acid solution with a high-speed homogenizer to form sustained-release granules;
[0016] 2. Put the antimicrobial peptide and slow-release granules together into a medical mixer for embedding to obtain antimicrobial peptide microparticles, and then embed the antimicrobial peptide microparticles with β-cyclodextrin to obtain antimicrobial peptide sustained-release microcapsules.
specific Embodiment approach 2
[0017] Specific embodiment two: the difference between this embodiment and specific embodiment one is: chitosan mass concentration is 0.25% (W / V)~1.5% (W / V) in the chitosan acid solution in the step 1, removes The degree of acetylation is 82% to 85%, and the molecular weight of chitosan is 3.3×10 5 ~4.6×10 5 of high molecular weight chitosan and a molecular weight of 0.72×10 5 ~1.19×10 5 The low molecular weight chitosan is composed according to the mass ratio of 1:1; and glucose is added into the chitosan acid solution, and the molar ratio of chitosan to glucose in the chitosan acid solution is 0.3-0.8. Other steps and parameters are the same as those in Embodiment 1.
[0018] In this embodiment, the concentration of the chitosan acid solution needs to be ≥0.25% (W / V), and the concentration of the chitosan acid solution increases, and the controllability of the microcapsules increases.
[0019] In this embodiment, glucose is added as a plasticizer, which can increase the ...
specific Embodiment approach 3
[0021] Embodiment 3: The difference between this embodiment and Embodiment 1 or 2 is that the mass concentration of sodium alginate in the sodium alginate aqueous solution in step 1 is 1.5% to 2.0%. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com